First Trust Advisors’s Antares Pharma, Inc. ATRS Stock Holding History

First Trust Advisors’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-260,704	Closed	-$1.07M	–	2660
2022 Q1	$1.07M	Sell	260,704 -15,133	-5%	-$54.9K	﹤0.01%	2028
2021 Q4	$985K	Buy	275,837 +34,189	+14%	+$120K	﹤0.01%	2063
2021 Q3	$880K	Buy	+241,648	New	+$977K	﹤0.01%	2082

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

First Trust Advisors's ATRS Position: Q2 2022 in Review

First Trust Advisors sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 260,704 shares — an estimated $1.07M sold.

First Trust Advisors first reported a position in ATRS in Q3 2021 and held it in 3 quarters. The position peaked at $1.07M in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

First Trust Advisors reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
First Trust Advisors sold 260,704 Antares Pharma, Inc. shares in Q2 2022, an estimated $1.07M.
First Trust Advisors first reported a position in Antares Pharma, Inc. in Q3 2021 and held it in 3 quarters.
First Trust Advisors's Antares Pharma, Inc. position peaked at $1.07M in Q1 2022.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on First Trust Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.